Abamectin/ Oxfendazole/Levamisole 5L & 10L
2 g/L Abamectin, 45.3 g/L Oxfendazole, 80 g/L Levamisole HCI, 5g/L Cobalt, 1 g/L Selenium
White/ML/Clear Triple Combination Oral is a Low Dose Drench for the treatment and control of internal parasites in Cattle and Sheep.
Treble Oral may be effective in some populations of gastrointestinal worms with single or dual resistance to the avermectin/milbemycin, benzimidazole or Levamisole/morantel anthelmintic action families
Aids in selenium and cobalt supplementation
At recommended dose, this product is effective for the treatment and control of the following mature and immature sensitive parasites of cattle and sheep
Gastrointestinal roundworms Haemonchus Contortus ( Barber’s Pole), Teladorsagia Ostertagia spp ( Small Brown Stomach Worm), Trichostrongylus spp, Nematodirus spp, Cooperia spp, , Bunostomum Strongyloides, Oesophagostomum, Chabertia, Trichuris,
Lungworm Dictyocaulu spp.
DIRECTIONS FOR USE
Shake well before use
Do not use in lambs under 20 kg or under 4 weeks of age
A representative sample of animals should be weighed before treatment Dose rate to be based on the heaviest animal in each group, do not underdose
Where there is a large variation in size within the group, dose rate should be based on the label directions for each weight range. Drafting into two or more lines may be appropriate, to avoid overdosing. Correct drenching technique should be used. Check the accuracy of drench guns regularly.
DOSE RATE: 1ml per 10kg bodyweight
| Bodyweight | Dose Volume | Doses per 10L |
| 20kg | 2mL | 5000 |
| 30kg | 3mL | 3332 |
| 40kg | 4mL | 2500 |
| 50kg | 5mL | 1000 |
| 60kg | 6mL | 1666 |
| 70kg | 7mL | 1428 |
| 80kg | 8mL | 1250 |
| 90kg | 9mL | 1111 |
MEAT: Sheep producing meat or offal for human consumption must not be sold for slaughter during or within 14 days of cessation of the last treatment.
MILK: Milk intended for sale for human consumption must be discarded during treatment and for not less than 35 days following the last treatment,
Registered pursuant to the ACVM Act I 997, No. A11495